Serum osteoprotegerin/osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers
Authors:
Open Access
- 1 August 2002
- journal article
- research article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 174 (2) , 353-359
Abstract
Pregnancy and lactation induce dynamic changes in maternal bone and calcium metabolism. A novel cytokine termed osteoprotegerin (OPG)/osteoclastogenesis-inhibitory factor (OCIF) was recently isolated; this cytokine inhibits osteoclast maturation. To define the effects of pregnancy and lactation on circulating OPG/OCIF in mothers, we studied the changes in the levels of OPG/ OCIF as well as those of calcium-regulating hormones and biochemical markers of bone turnover in the maternal circulation during pregnancy (at 8-11 weeks, at 22-30 weeks, at 35-36 weeks and immediately before delivery) and lactation (at 4 days and at 1 month postpartum). Serum intact parathyroid hormone levels did not change and were almost within the normal range in this period. In contrast, serum 1,25-dihydroxyvitamin D levels increased with gestational age and were above the normal range during pregnancy. After delivery, they fell rapidly and significantly (P<0.01) to the normal range. The levels of serum bone-specific alkaline phosphatase, one of the markers of bone formation, increased with gestational age. After delivery, these levels were further increased at 1 month postpartum. The levels at 1 month postpartum were significantly higher than those at 8-11 and 22-30 weeks of pregnancy (P<0.01 and P<0.05 respectively). The levels of serum C-terminal telopeptides of type I collagen, one of the markers of bone resorption, did not change during pregnancy. After delivery, they rapidly and significantly (P<0.01) rose at 4 days postpartum, and had then fallen by 1 month postpartum. Circulating OPG/OCIF levels gradually increased with gestational age and significantly (P<0.01) increased immediately before delivery to 1.40+/-0.53 ng/ml (means+/-S.D.) compared with those in the non-pregnant, non-lactating controls (0.58+/-0.11 ng/ml). After delivery, they fell rapidly to 0.87+/-0.27 ng/ml at 4 days postpartum and had fallen further by 1 month postpartum. These results suggest that the fall in OPG/OCIF levels may be partially connected with the marked acceleration of bone resorption after delivery.Keywords
This publication has 22 references indexed in Scilit:
- Immunological Study on Circulating Murine Osteoprotegerin/Osteoclastogenesis Inhibitory Factor (OPG/OCIF): Possible Role of OPG/OCIF in the Prevention of Osteoporosis in PregnancyBiochemical and Biophysical Research Communications, 2001
- The Effect of a Single Dose of Osteoprotegerin in Postmenopausal WomenJournal of Bone and Mineral Research, 2001
- Immunological Characterization of Circulating Osteoprotegerin/Osteoclastogenesis Inhibitory Factor: Increased Serum Concentrations in Postmenopausal Women with OsteoporosisJournal of Bone and Mineral Research, 1999
- Effects of Calcium Supplementation on Calcium Homeostasis and Bone Turnover in Lactating Women1The Journal of Clinical Endocrinology & Metabolism, 1999
- The Effect of Calcium Supplementation on Bone Density during Lactation and after WeaningNew England Journal of Medicine, 1997
- Isolation of a Novel Cytokine from Human Fibroblasts That Specifically Inhibits OsteoclastogenesisBiochemical and Biophysical Research Communications, 1997
- Elevated Parathyroid Hormone-Related Peptide Associated With Lactation and Bone Density LossJAMA, 1996
- Bone turnover and density in healthy women during breastfeeding and after weaningOsteoporosis International, 1996
- Human lactation: Forearm trabecular bone loss, increased bone turnover, and renal conservation of calcium and inorganic phosphate with recovery of bone mass following weaningJournal of Bone and Mineral Research, 1990
- Calcium metabolism in pregnancy and the perinatal period: A reviewAmerican Journal of Obstetrics and Gynecology, 1985